Compartir
Modulators, Mediators, and Specifiers in Brain Function: Interactions of Neuropeptides, Cyclic Nucleotides, and Phosphoproteins in Mechanisms Underlyi (en Inglés)
Erlich, Y. H. (Autor)
·
Springer
· Tapa Blanda
Modulators, Mediators, and Specifiers in Brain Function: Interactions of Neuropeptides, Cyclic Nucleotides, and Phosphoproteins in Mechanisms Underlyi (en Inglés) - Erlich, Y. H.
$ 92.60
$ 142.46
Ahorras: $ 49.86
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Martes 13 de Agosto y el
Martes 27 de Agosto.
Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Modulators, Mediators, and Specifiers in Brain Function: Interactions of Neuropeptides, Cyclic Nucleotides, and Phosphoproteins in Mechanisms Underlyi (en Inglés)"
While neuroanatomy and neurophysiology were defining the unique features of the synapse as a site for cell to cell signaling in the late fifties, neurochemistry was establishing the identity and studying the biosynthetic pathways of monoamine neurotransmitters. Meanwhile, neuropsychiatry was keeping a vigilant eye on the outcome of this concerted effort with the untold hope that a genetic defect in neurotransmitter metabolism would ac- count for the pathogenesis of certain psychiatric ill- nesses. Thus, when neurochemists in the early sixties began to study the feasibility of measuring the metabolism of brain neurotransmitters in vivo, clinical biochemists eagerly adopted these methods to their needs and sought to verify whether inborn errors of transmitter biogenesis were a cause for at least certain forms of depression, mania and schizophrenia. Undoubtedly, it is still too early to evaluate the outcome of these studies. However, current opinion holds that gross inborn errors in transmitter metabolism do not anpear to be operative as a primary cause of psychia- tric disorders. Though monoamine metabolism appears to be defective in certain groups of psychiatric disorders, the cause of these changes can at best be associated with changes in patterns of neuronal firing. It is generally believed that these persistent changes are determined by a number of unknown factors operative in various psychia- tric illnesses. In the attempt to identify the molecular nature of these unknown factors, the focus of current research is directed toward transmitter receptors.